高级检索
    崔久嵬, 高玉儿. Capmatinib在MET 14外显子突变或MET扩增非小细胞肺癌中的疗效及安全性[J]. 循证医学, 2020, 20(5): 272-275. DOI: 10.12019/j.issn.1671-5144.2020.05.005
    引用本文: 崔久嵬, 高玉儿. Capmatinib在MET 14外显子突变或MET扩增非小细胞肺癌中的疗效及安全性[J]. 循证医学, 2020, 20(5): 272-275. DOI: 10.12019/j.issn.1671-5144.2020.05.005
    shu
    CUI Jiu-wei, GAO Yu-er. Efficacy and Safety of Capmatinib in MET Exon 14 Mutated or MET Amplified Non-Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 272-275. DOI: 10.12019/j.issn.1671-5144.2020.05.005
    Citation: CUI Jiu-wei, GAO Yu-er. Efficacy and Safety of Capmatinib in MET Exon 14 Mutated or MET Amplified Non-Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 272-275. DOI: 10.12019/j.issn.1671-5144.2020.05.005
    shu

    Capmatinib在MET 14外显子突变或MET扩增非小细胞肺癌中的疗效及安全性

    Efficacy and Safety of Capmatinib in MET Exon 14 Mutated or MET Amplified Non-Small-Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(4)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回